Investigator survey prompts company to develop new on-line logistics services
Research Triangle Park, North Carolina, December 17, 2015 – Marken today announced the results of their recent survey of investigator sites in Latin America, which identified Marken as the leader in transporting biologic specimens from the region to central labs in the United States.
The survey was conducted over a three month period by contacting 1,497 active clinical investigator sites in 11 Latin America countries. 903 respondents were asked several standard questions. Nearly all of the respondents report that they utilize multiple couriers but 94% of them are currently working with Marken. A clear majority of the investigator sites indicated that Marken is their preferred courier. Their reasons for preferring Marken included: flexibility, customer service, on time delivery and ‘easy to work with’. The survey confirmed that Marken is the clear leader in the region.
Over 49% of the sites use two or three CRO / central lab companies, and an additional 14% indicate they work with six or more. Export documentation is becoming more complex, leading to excess investigator paperwork. Reviewing the survey results, Marken saw the need to improve investigator’s workflow by developing a protocol-specific electronic booking tool to greatly reduce the work at the sites and also facilitate more efficient tracking of their shipments. Marken’s new on-line tool is called MaestroTM Allegro. The downloadable ‘App’ populates all of the required fields to make scheduling and export documentation an easy process, specific to a trial and an investigator site. Allegro will be available in Spanish and Portuguese and rolled out in January.
Wes Wheeler, Chief Executive Officer, commented, “We were also pleased to learn from the survey that though the market has many choices, the survey indicated that Marken was chosen as the preferred logistics partner of choice by over 500 investigator sites in Latin America over six other providers. We greatly value this feedback and will respond with continued service upgrades and technology investments in Latin America and to the 49,000 investigator sites we serve globally.”
To read the full survey results, request a copy by emailing firstname.lastname@example.org.
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken’s 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
CONTACT: Christine Noble, email@example.com, +1 919 474 6890, www.marken.com